However, the precise mechanisms underlying these relationships and their implications for the development and treatment of neurological disorders require further investigation
Disclosure of interest: Xinjie Gao: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P158 - ESOC25-1869 ACCURACY OF AUTOMATED HEMORRHAGE SUBTYPE DETECTION IN SUSPECTED INTRACEREBRAL HEMORRHAGE James Garrard 1,2 , Artem Kaliaev 3 , Asim Mian 3 , Chad Farris 3 , Pau Bellot 1 , Olivier Joly 1 , Zoe Woodhead 1 , James Briggs 1,4 , Davide Carone *1 , George Harston 1,2 , Mohamad Abdalkader 3 1 Brainomix, OXFORD, United Kingdom, 2 Oxford University Hospitals, OXFORD, United Kingdom, 3 Boston Medical Centre, Boston, United States, 4 Royal Berkshire Hospital, Reading, United Kingdom Background and Aims: Early identification of patients with intracerebral hemorrhage (ICH) is thought to be critical to improve outcomes through earlier implementation of evidence-based care-bundles
Book Your Appointment Today Same-week appointments are often available
Standard injectable dosing ranges from 0.25 mg to 0.5 mg daily for most applications
Its 2030-hour half-life means that a single administration produces a prolonged elevation of free IGF1R-binding peptide, making it well-suited for in vivo anabolic or metabolic studies in which continuous infusion is impractical
